The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II ...

Sol-Gel has developed Twyneo, which is approved by the FDA for ... and commercialization of a generic drug product to Zoryve Cream (roflumilast cream 0.3%). The company’s top line currently ...

The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II ...